+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Neurostimulation Devices Market By Devices, By Applications, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5094288
  • Report
  • May 2020
  • Region: Asia Pacific
  • 97 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • LivaNova PLC
  • Medtronic PLC
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
The Asia Pacific Neurostimulation Devices Market is expected to witness market growth of 13.9% CAGR during the forecast period (2020-2026).

Increased mental health awareness and the prevalence of neurological diseases along with numerous initiatives taken up by the government and private entities have been contributing to the exponential market growth. Factors such as improved healthcare infrastructure, an increasing number of healthcare reforms, and extensive healthcare spending in emerging markets such as India and China to overcome unmet medical needs in these regions are boosting demand for neurostimulators.

The rapid rise of COVID-19 infections leads to an increased concern for the shortage of essential life-saving devices and other vital health care to prevent the spread of this pandemic and provide the infected with optimum care. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide variety of test-kits (antibody samples, self-administered, and others) require a rapid acceleration in the manufacturing process.

In conjunction with the available limited treatment options for the disease, the high product efficiency in the treatment of epilepsy is expected to boost market growth throughout the forecast period. Essential tremor is characterized by severe unintentional limb movement. The condition has an impact on the neck, jaw, and other parts of the body. The rising global population of geriatric diseases is among the most significant causes of tremor. Rising depression cases are also likely to contribute to the market development as neurostimulation equipment can easily handle electrical brain signals by activating or inhibiting them.

Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.

Scope of the Study

Market Segmentation:

By Devices
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators and
  • Other Devices

By Applications
  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's Disease
  • Epilepsy and
  • Other Applications

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corporation
  • Medtronic PLC
  • NeuroSigma, Inc.
  • Integer Holdings Corporation
  • LivaNova PLC
  • NeuroPace, Inc.
  • Neuronetics, Inc.
  • Synapse BioMedical, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • LivaNova PLC
  • Medtronic PLC
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neurostimulation Devices Market, by Devices
1.4.2 Asia Pacific Neurostimulation Devices Market, by Applications
1.4.3 AsiaPacific Neurostimulation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Oct - 2020, May) Leading Players
Chapter 4. Asia Pacific Neurostimulation Devices Market by Devices
4.1 Asia Pacific Spinal Cord Stimulators Market by Country
4.2 Asia Pacific Deep Brain Stimulators Market by Country
4.3 Asia Pacific Sacral Nerve Stimulators Market by Country
4.4 Asia Pacific Vagus Nerve Stimulators Market by Country
4.5 Asia Pacific Other Devices Market by Country
Chapter 5. Asia Pacific Neurostimulation Devices Market by Applications
5.1 Asia Pacific Pain Management Market by Country
5.2 Asia Pacific Hearing Loss Market by Country
5.3 Asia Pacific Urinary Incontinence Market by Country
5.4 Asia Pacific Parkinson's Disease Market by Country
5.5 Asia Pacific Epilepsy Market by Country
5.6 Asia Pacific Other Applications Market by Country
Chapter 6. Asia Pacific Neurostimulation Devices Market by Country
6.1 China Neurostimulation Devices Market
6.1.1 China Neurostimulation Devices Market by Devices
6.1.2 China Neurostimulation Devices Market by Applications
6.2 India Neurostimulation Devices Market
6.2.1 India Neurostimulation Devices Market by Devices
6.2.2 India Neurostimulation Devices Market by Applications
6.3 Japan Neurostimulation Devices Market
6.3.1 Japan Neurostimulation Devices Market by Devices
6.3.2 Japan Neurostimulation Devices Market by Applications
6.4 South Korea Neurostimulation Devices Market
6.4.1 South Korea Neurostimulation Devices Market by Devices
6.4.2 South Korea Neurostimulation Devices Market by Applications
6.5 Singapore Neurostimulation Devices Market
6.5.1 Singapore Neurostimulation Devices Market by Devices
6.5.2 Singapore Neurostimulation Devices Market by Applications
6.6 Malaysia Neurostimulation Devices Market
6.6.1 Malaysia Neurostimulation Devices Market by Devices
6.6.2 Malaysia Neurostimulation Devices Market by Applications
6.7 Rest of Asia Pacific Neurostimulation Devices Market
6.7.1 Rest of Asia Pacific Neurostimulation Devices Market by Devices
6.7.2 Rest of Asia Pacific Neurostimulation Devices Market by Applications
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments
7.1.5.1 Partnerships, Collaborations, and Agreements
7.1.5.2 Approvals
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments
7.2.5.1 Acquisition and Mergers
7.2.5.2 Product Launches and Product Expansions
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments
7.3.5.1 Approvals
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments
7.4.5.1 Partnerships, Collaborations, and Agreements
7.4.5.2 Acquisition and Mergers
7.4.5.3 Product Launches and Product Expansions
7.4.5.4 Approvals
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments
7.5.2.1 Partnerships, Collaborations, and Agreements
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments
7.7.5.1 Approvals
7.7.5.2 Acquisition and Mergers
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments
7.8.2.1 Approvals
7.8.2.2 Product Launches and Product Expansions
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments
7.9.5.1 Partnerships, Collaborations, and Agreements
7.9.5.2 Approvals
7.10 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments
7.10.2.1 Approvals
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corporation
  • Medtronic PLC
  • NeuroSigma, Inc.
  • Integer Holdings Corporation
  • LivaNova PLC
  • NeuroPace, Inc.
  • Neuronetics, Inc.
  • Synapse BioMedical, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...